Table 3 Characteristics of the responder–relapser patients
VariablePatients
No.11
Gender (male, n (%))8 (73)
Age (years)50.7 (6.2)
Source of infection (n (%))
    Blood transfusion3 (27)
    Intravenous drug use3 (27)
    Unknown5 (45)
ALT (IU/l, median)123 (54)
HCV genotype (n)
    13
    21
    35
    42
    50
Stage (n)
    F13
    F24
    F34
    F40
  • ALT, alanine aminotransferase; HCV, hepatitis C virus.